The Potential Protective Effect of Using Muscle Relaxants During Electroporation Ablation (PFA)
The Potential Protective Effect of Using Muscle Relaxants During Electroporation Ablation (PFA)
Recruiting · NCT06707532 · Registry updated 2024-11-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Potential Protective Effect of Using Muscle Relaxants During Electroporation Ablation (PFA) | Arrhythmias, Cardiac, Chemically-Induced Disorders, Chronic Pain, Drug-Related Side Effects and Adverse Reactions, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Muscle Hypotonia, Myotoxicity, Neurologic Manifestations, Neuromuscular Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Succinylcholine Sensitivity, Urogenital Diseases, acute kidney injury, butyrylcholinesterase deficiency, cardiovascular disorder, heart disorder, injury, kidney disorder, kidney failure, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, neuromuscular disease, radiation injury, urinary system disorder | Recruiting | Not applicable | 2024-11-27 | NCT06707532 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| 4th Military Clinical Hospital with Polyclinic, Poland | 8 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| 4th Military Clinical Hospital with Polyclinic | Wroclaw | Poland | 2 |